• In August 2026, Amprius Technologies reported second-quarter 2026 sales of US$34.03 million and a net loss of US$3.15 million, while also raising full-year 2026 guidance to at least US$140 million in revenue and a net loss of under US$10 million, including a US$1.9 million non-cash warrant-related charge.
• Beyond the headline guidance increase, management attributed the stronger outlook to improving manufacturing economics and growing demand from drone and European customers, highlighting the importance of its NDAA-compliant supply and U.S. manufacturing partnerships.
• We will now examine how Amprius’ upgraded 2026 revenue outlook and improved loss guidance reshape its longer-term investment narrative.

We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Amprius Technologies Investment Narrative Recap

To own Amprius, you have to believe its silicon anode batteries can convert early traction in drones and aerospace into a broader, sustainable business, while moving closer to profitability. The latest guidance raise to at least US$140 million in 2026 revenue and a net loss under US$10 million supports the near term catalyst around scaling production economics, but it does not remove the key risk of heavy exposure to aviation and drone demand cycles.

Among recent announcements, the February 2026 manufacturing partnership with Nanotech Energy stands out here, because it points to a potential U.S. production path that complements Amprius’ contract manufacturing model in Korea and China. For investors focused on catalysts, this matters: if the contract model is a strength today, any disruption or delay in diversifying supply, especially for NDAA sensitive customers, could quickly become a weakness.

Yet, behind the stronger 2026 outlook, investors should still weigh how concentrated drone and aviation demand leaves Amprius exposed if...

Amprius Technologies' narrative projects $415.0 million revenue and $53.6 million earnings by 2029. This requires 66.3% yearly revenue growth and a $93.3 million earnings increase from -$39.7 million today.

Uncover how Amprius Technologies' forecasts yield a $22.12 fair value, a 87% upside to its current price.

Exploring Other Perspectives

Before this guidance, the most pessimistic analysts already assumed rapid growth, with revenue reaching about US$362 million and earnings of roughly US$40 million by 2029, yet they still flagged execution and volatility risks much more sharply than the consensus narrative, reminding you that expectations can shift quite a lot as new information like this guidance comes through.

Explore 10 other fair value estimates on Amprius Technologies - why the stock might be worth just $12.25!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Amprius Technologies research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Amprius Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Amprius Technologies' overall financial health at a glance.

Looking For Alternative Opportunities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• The future of work is here. Discover the 37 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.